Literature DB >> 17099512

Protective effects of heme-oxygenase expression against endotoxic shock: inhibition of tumor necrosis factor-alpha and augmentation of interleukin-10.

Fabienne Tamion1, Vincent Richard, Sylvanie Renet, Christian Thuillez.   

Abstract

BACKGROUND: Heme-oxygenase (HO)-1 acts as an inducible defense against oxidative stress and could play an important role in inflammation models, providing protection against oxidative stress and systemic inflammatory response. The objective of this study was to improve the role of HO-1 on systemic inflammatory response in an endotoxic shock model.
METHODS: Five groups of animals were used: control group; lipopolysaccharide (LPS) group, animals received LPS 5 mg/kg; hemin + LPS group, animals received pretreatment with hemin, used to induce HO-1 expression; Zn-PP group, animals received Zn-PP, a specific inhibitor of HO-1 activity and hemin group. At the end of the experiment, tissue and blood samples were isolated for the measurement of HO-1 mRNA expression, biochemical measurements, and cytokine measurements.
RESULTS: HO-1 messenger RNA expression and protein were induced to a larger extent in LPS group in distal organs. Hemin pretreatment induced a significant decrease oxidative stress and tumor necrosis factor-alpha plasma levels with a significant increase of interleukin-10 plasma levels. Pulmonary injury was markedly limited after hemin. Onset of lethality in LPS group occurred at H6, and was delayed until H10 with hemin. Inhibition of HO-1 activity by Zn-PP administration abolished the beneficial effect of hemin-pretreatment.
CONCLUSIONS: Early HO-1 expression may modulate systemic inflammatory response and limit end-organ injury in endotoxic shock model.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17099512     DOI: 10.1097/01.ta.0000239359.41464.ef

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  19 in total

1.  Monocyte deactivation correlates with injury severity score, but not with heme oxygenase-1 levels in trauma patients.

Authors:  Sonlee D West; Carolyn Mold
Journal:  J Surg Res       Date:  2011-05-05       Impact factor: 2.192

2.  Heme oxygenase (HO)-1 protects from lipopolysaccharide (LPS)-mediated liver injury by inhibition of hepatic leukocyte accumulation and improvement of microvascular perfusion.

Authors:  Jonas Roller; Matthias W Laschke; Claudia Scheuer; Michael D Menger
Journal:  Langenbecks Arch Surg       Date:  2010-03-17       Impact factor: 3.445

3.  Upregulation of HO-1 Attenuates LPS-Stimulated Proinflammatory Responses Through Downregulation of p38 Signaling Pathways in Rat Ovary.

Authors:  Lian Li; Juan Tang; Yu Sun; Jie Wu; Pan Yu; Genlin Wang
Journal:  Inflammation       Date:  2015       Impact factor: 4.092

4.  Heme oxygenase-1 is induced in peripheral blood mononuclear cells of patients with acute pancreatitis: a potential therapeutic target.

Authors:  Aida Habtezion; Raymond Kwan; Alice L Yang; Maureen E Morgan; Ehsaan Akhtar; Stephen P Wanaski; Stephen D Collins; Eugene C Butcher; Ahmad Kamal; M Bishr Omary
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-10-21       Impact factor: 4.052

Review 5.  The role of heme oxygenase and carbon monoxide in inflammatory bowel disease.

Authors:  Tomohisa Takagi; Yuji Naito; Kazuhiko Uchiyama; Toshikazu Yoshikawa
Journal:  Redox Rep       Date:  2010       Impact factor: 4.412

6.  Endogenous IL-10 regulates sepsis-induced thymic apoptosis and improves survival in septic IL-10 null mice.

Authors:  S K Tschoeke; C Oberholzer; D LaFace; B Hutchins; L L Moldawer; A Oberholzer
Journal:  Scand J Immunol       Date:  2008-10-08       Impact factor: 3.487

7.  Beneficial effects of the heme oxygenase-1/carbon monoxide system in patients with severe sepsis/septic shock.

Authors:  Shoji Takaki; Naoshi Takeyama; Yuka Kajita; Teru Yabuki; Hiroki Noguchi; Yasuo Miki; Yasusuke Inoue; Takashi Nakagawa; Hiroshi Noguchi
Journal:  Intensive Care Med       Date:  2009-09-29       Impact factor: 17.440

Review 8.  Regulation of haeme oxygenase-1 for treatment of neuroinflammation and brain disorders.

Authors:  P J Syapin
Journal:  Br J Pharmacol       Date:  2008-09-15       Impact factor: 8.739

9.  Involvement of gaseous low molecular monoxides in the cutaneous reverse passive Arthus reaction: cytoprotective action of carbon monoxide.

Authors:  K Shimizu; S J Bae; T Hara; Y Iwata; T Yamaoka; K Komura; E Muroi; M Takenaka; F Ogawa; S Sato
Journal:  Clin Exp Immunol       Date:  2008-05-26       Impact factor: 4.330

10.  Heme oxygenase-1: its therapeutic roles in inflammatory diseases.

Authors:  Hyun-Ock Pae; Hun-Taeg Chung
Journal:  Immune Netw       Date:  2009-02-28       Impact factor: 6.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.